Christopher Downs - Net Worth and Insider Trading
Christopher Downs Net Worth
The estimated net worth of Christopher Downs is at least $230,188 dollars as of 2024-05-12. Christopher Downs is the CFO (interim) of InfuSystems Holdings Inc and owns about 28,840 shares of InfuSystems Holdings Inc (INFU) stock worth over $209,955. Christopher Downs is also the CFO of CNS Pharmaceuticals Inc and owns about 103,438 shares of CNS Pharmaceuticals Inc (CNSP) stock worth over $20,232. Details can be seen in Christopher Downs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Downs has not made any transactions after 2024-02-01 and currently still holds the listed stock(s).
Transaction Summary of Christopher Downs
Christopher Downs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Downs owns 3 companies in total, including CNS Pharmaceuticals Inc (CNSP) , InfuSystems Holdings Inc (INFU) , and EBET Inc (EBET) .
Click here to see the complete history of Christopher Downs’s form 4 insider trades.
Insider Ownership Summary of Christopher Downs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNSP | CNS Pharmaceuticals Inc | 2024-02-01 | Chief Financial Officer |
| INFU | InfuSystems Holdings Inc | 2017-08-14 | CFO (interim) |
| EBET | EBET Inc | 2021-04-14 | director |
Christopher Downs Latest Holdings Summary
Christopher Downs currently owns a total of 2 stocks. Among these stocks, Christopher Downs owns 28,840 shares of InfuSystems Holdings Inc (INFU) as of August 14, 2017, with a value of $209,955 and a weighting of 91.21%. Christopher Downs also owns 103,438 shares of CNS Pharmaceuticals Inc (CNSP) as of February 1, 2024, with a value of $20,232 and a weighting of 8.79%.
Latest Holdings of Christopher Downs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INFU | InfuSystems Holdings Inc | 2017-08-14 | 28,840 | 7.28 | 209,955 |
| CNSP | CNS Pharmaceuticals Inc | 2024-02-01 | 103,438 | 0.20 | 20,232 |
Holding Weightings of Christopher Downs
Christopher Downs Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Downs has made a total of 0 transactions in InfuSystems Holdings Inc (INFU) over the past 5 years. The most-recent trade in InfuSystems Holdings Inc is the acquisition of 7,900 shares on August 14, 2017, which cost Christopher Downs around $15,010.
According to the SEC Form 4 filings, Christopher Downs has made a total of 6 transactions in CNS Pharmaceuticals Inc (CNSP) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in CNS Pharmaceuticals Inc is the acquisition of 66,666 shares on February 1, 2024, which cost Christopher Downs around $20,000.
Insider Trading History of Christopher Downs
- 1
Christopher Downs Trading Performance
GuruFocus tracks the stock performance after each of Christopher Downs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Downs is -18.86%. GuruFocus also compares Christopher Downs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Downs within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Downs's insider trading performs compared to the benchmark.
Performance of Christopher Downs
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.72 | | | | | |
| Relative Return to S&P 500(%) | -16.69 | | | | | |
Christopher Downs Ownership Network
Christopher Downs Owned Company Details
What does CNS Pharmaceuticals Inc do?
Who are the key executives at CNS Pharmaceuticals Inc?
Christopher Downs is the Chief Financial Officer of CNS Pharmaceuticals Inc. Other key executives at CNS Pharmaceuticals Inc include director & Chief Executive Officer John M Climaco , and 10 percent owner Waldemar Priebe .
CNS Pharmaceuticals Inc (CNSP) Insider Trades Summary
Over the past 18 months, Christopher Downs made 3 insider transaction in CNS Pharmaceuticals Inc (CNSP) with a net purchase of 96,766. Other recent insider transactions involving CNS Pharmaceuticals Inc (CNSP) include a net purchase of 184,416 shares made by John M Climaco , a net purchase of 43,006 shares made by Jerzy Gumulka , and a net sale of 94,298 shares made by Waldemar Priebe .
In summary, during the past 3 months, insiders sold 0 shares of CNS Pharmaceuticals Inc (CNSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 94,298 shares of CNS Pharmaceuticals Inc (CNSP) were sold and 357,521 shares were bought by its insiders, resulting in a net purchase of 263,223 shares.
CNS Pharmaceuticals Inc (CNSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CNS Pharmaceuticals Inc Insider Transactions
Christopher Downs Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Downs. You might contact Christopher Downs via mailing address: 31700 Research Park Drive, Madison Heights Mi 48071.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
